Next Article in Journal
The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review
Previous Article in Journal
Importance of an Ongoing Nutritional Counselling Intervention on Eating Habits of Newly Diagnosed Children with Celiac Disease
Previous Article in Special Issue
The Accumulative Effect of Multiple Postnatal Risk Factors with the Risk of Being Overweight/Obese in Late Childhood
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 16
Issue 15
10.3390/nu16152419
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Associations of Obstructive Sleep Apnea Risk with Obesity, Body Composition and Metabolic Abnormalities in School-Aged Children and Adolescents

by
Zijun Liao
,
Yiren Chen
,
Lijun Wu
,
Yiying Huang
,
Shaoli Li
,
Junting Liu
,
Xinnan Zong
,
Jun Tai
* and
Fangfang Chen
*
Capital Institute of Pediatrics, Beijing 100020, China
*
Authors to whom correspondence should be addressed.
Nutrients 2024, 16(15), 2419; https://doi.org/10.3390/nu16152419
Submission received: 28 June 2024 / Revised: 17 July 2024 / Accepted: 22 July 2024 / Published: 25 July 2024
(This article belongs to the Special Issue Nutrition in Early Life and Its Impact through the Life Course)
Browse Figure
Versions Notes

Abstract

:
The objective of this study is to explore the associations between obesity, body composition, and the self-reported risk of obstructive sleep apnea (OSA) and to examine whether the risk of OSA is related to metabolic abnormalities in children and adolescents aged 6–17 years. Utilizing data from the 2022 to 2023 Beijing Children and Adolescents Health Cohort baseline survey, 5000 school-aged participants were analyzed. OSA risk was assessed via the Pediatric Sleep Questionnaire, with anthropometric and body composition measurements taken. Metabolic markers included blood pressure, lipid levels, blood glucose, and uric acid. Associations were analyzed using logistic regression and generalized linear models. Results showed that 88.6% were low-risk and 11.4% were high-risk for OSA. Overweight (aOR 1.53, 95% CI 1.22–1.92), obesity (aOR 1.94, 95% CI 1.57–2.40), and abdominal obesity (aOR 1.59, 95% CI 1.31–1.93) significantly increased OSA risk. High fat mass was a critical factor, while muscle mass was not, especially in those who were overweight and obese. Associations of OSA risk with metabolic abnormalities were non-significant after adjusting for BMI. Our research highlights the significant associations of obesity and body composition with OSA risk, with child BMI influencing the relationship between OSA and metabolic abnormalities. Future research should explore causative relationships and the enduring impacts of OSA on metabolic health in children.

1. Introduction

Obstructive sleep apnea (OSA) is a condition defined by the frequent occurrence of either a total or partial collapse of the upper respiratory tract, resulting in intermittent oxygen deprivation and hypercapnia [1]. The rate of OSA is on the rise and is prevalent among children [2]. Untreated OSA is linked to negative health outcomes that include behavioral problems, decreased neurocognitive development, and metabolic abnormalities [2].
Childhood obesity, which has also been on the rise globally, is a risk factor for pediatric OSA; excessive fat deposition in the throat and neck, together with larger adenoids and tonsils, primarily contributes to OSA [3,4,5,6]. For school-aged children and adolescents, obesity may play a more substantial role than adenotonsillar hypertrophy [7]. Research in adults has shown that sarcopenic obesity, rather than obesity alone, is associated with OSA, indicating a complex connection between unhealthy body composition and OSA [8]. In obese children, the neck-to-abdominal fat percentage is also significant in the development of OSA [9]. However, the impacts of comprehensive body composition on OSA, especially in normal-weight children, remain unclear. Understanding the correlations involving obesity, body composition, and OSA risk in children and adolescents is critical for developing effective interventions.
OSA impacts metabolic markers such as blood pressure and lipids, but the results are inconsistent regarding whether OSA exerts an effect independent of obesity [6,10,11,12,13,14,15]. Most research has focused on a limited range of markers, making it challenging to comprehensively assess the impacts of OSA on metabolic health. This study considers weight status when exploring the associations between OSA and metabolic markers, investigating a complete spectrum of metabolic markers including blood pressure, lipid levels, blood glucose, and uric acid.
Polysomnography (PSG) is considered the gold standard for OSA diagnosis [16]. Nevertheless, the available resources frequently prove insufficient to manage the substantial influx of referrals for testing, leading to long wait times for pediatric PSG [17]. Furthermore, the cost of PSG makes it unlikely to be used as a monitoring tool. Therefore, it is crucial to identify children who are at risk for OSA based on obesity and body composition and to understand the negative changes in children with high risk of OSA to prioritize PSG testing effectively.
The objective of this study is to examine whether obesity and body composition are associated with self-reported risk for OSA and whether the risk for OSA is related to metabolic abnormalities in children and adolescents between the ages of 6 and 17.

2. Materials and Methods

This report adhered to the reporting guidelines of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement [18].

2.1. Study Design and Participants

The data for this study were obtained from the baseline survey in the Beijing Children and Adolescents Health Cohort conducted from 2022 to 2023, which was a prospective cohort study design established in a district of Beijing, China. The cohort consisted of 11 representative kindergartens and primary and secondary schools, including a total of 6013 participants aged 3–17 years. The study was carried out following the Declaration of Helsinki and received approval from the Ethics Committee of the Capital Institute of Pediatrics (SHERLL2022043).

2.2. Data Collection and Measurements

2.2.1. Sleep Assessment

The parents of pediatric participants completed the questionnaires, with the child’s help if necessary. The Pediatric Sleep Questionnaire (PSQ) was a recommended screening questionnaire in the American Academy of Pediatrics OSA guidelines, and the validated simplified Chinese version of PSQ was used to assess OSA risk [19,20,21]. The PSQ comprises 22 yes/no items, with “yes” scored as 1 and “no” scored as 0; a total score of 7 or higher is considered indicative of high risk for OSA [19,20].

2.2.2. Anthropometric Measurements

The height of the children was measured without shoes using a mechanical stadiometer (Harpenden Portable Stadiometer, Crymych, Dyfed, UK) by trained staff. After a calm expiration, the waist circumference was measured horizontally around the navel. The body composition analyzer (H-Key350, Beijing Seehigher Technology Co., Ltd., Beijing, China) using segmental multi-frequency bioelectrical impedance analysis (BIA) was employed to measure body weight and body composition, including percentage of fat mass (FM%), fat mass, fat-free mass, total muscle mass, and trunk fat mass [22,23]. Total muscle mass is estimated based on measurements of fat-free mass in the trunk and limbs. Children must be fasting and have an empty bladder prior to measurements. The formulas for calculating body mass index (BMI), fat mass index (FMI), fat-free mass index (FFMI), and total muscle mass index (TMMI) were the corresponding mass in kilograms divided by the square of height in meters, respectively [22]. The central fat mass index (CFMI) was calculated as trunk fat mass in kilograms divided by the square of height in meters [24]. The fat-to-muscle mass ratio (FMR) was computed as total body fat mass divided by muscle mass [25].
Based on the WHO growth standards, BMI z score (zBMI) was calculated age- and sex-standardized [26,27,28], and children with zBMI above +1 SD were classified as overweight, while those with zBMI above +2 SD were classified as obese, respectively [27,29,30]. Abdominal obesity was defined by a waist-to-height ratio (WHtR) equal to or greater than 0.5 [31,32,33]. The FMI and TMMI were also age- and sex-standardized. Body composition phenotypes were derived based on whether FMI and TMMI z scores were ≥1, resulting in four phenotypes: normal fat-normal muscle mass, normal fat-high muscle mass, high fat-normal muscle mass, and high fat-high muscle mass [34].

2.2.3. Metabolic Indicators

Blood pressure in mmHg, including systolic blood pressure (SBP) and diastolic blood pressure (DBP), was measured three times using an oscillometric sphygmomanometer (HBP-1300, Omron, Kyoto, Japan) on the right upper arm. Venous blood (5 mL) was collected after 12 h of fasting. The levels of serum total cholesterol (TC), triglycerides (TG), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), uric acid (UA), and fasting plasma glucose (FPG) were measured by a Siemens Automatic Biochemistry Analyzer (ADVIA 2400, Siemens, Erlangen, Germany).
Metabolic abnormalities were defined as follows: hypertension was defined as an SBP and/or DBP that was equal to or greater than the 95th percentile for individuals of the same sex, age, and height percentile population [35,36]. High TC levels were defined as TC concentration equal to or greater than 5.17 mmol/L; high TG levels were defined as TG equal to or greater than 1.12 mmol/L for children aged ≤9 years and 1.46 mmol/L for those aged ≥10 years; low HDL-C levels were defined as HDL-C concentration less than 1.03 mmol/L; and high LDL-C levels were defined as LDL-C concentration equal to or greater than 3.36 mmol/L [37]. Impaired fasting glucose (IFG) was defined as FPG equal to or greater than 5.6 mmol/L [38]. High UA levels were defined as UA concentrations greater than 420 mmol/L for boys and 360 mmol/L for girls [39].

2.2.4. Covariates

The study collected data on various potential covariates using questionnaires. These covariates included maternal age at delivery, maternal history of gestational diabetes mellitus/hypertension, delivery mode, child sex, birthweight, exclusive breastfeeding duration in the first six months, family history of metabolic abnormalities, annual family income, maternal education, paternal education, maternal current BMI, paternal current BMI, child age, sugary beverage consumption pattern, and passive smoking in the past week.

2.3. Statistical Analyses

Differences between groups of OSA risk were compared using the t-test for means, the Kruskal–Wallis test for medians, and the chi-square test for frequencies.
Associations of obesity, abdominal obesity, and body composition phenotypes with OSA risk were evaluated using logistic regression models. Multivariate models adjusted for maternal age at delivery (<35, ≥35 years), maternal history of gestational diabetes mellitus/hypertension (without, with), delivery mode (vaginal delivery, cesarean delivery), child sex (male, female), exclusive breastfeeding duration in the first six months (yes, no), family history of metabolic abnormalities (without, with), annual family income (<20,000, 20,000–120,000, 120,000–250,000, ≥250,000 CNY), maternal education (high school or less, college, above college), paternal education (high school or less, college, above college), child age, sugary beverage consumption pattern (≥1/day, 4–6/week, 1–3/week, ≤3/month), and passive smoking in the past week (yes, no). The odds ratio (OR) and 95% confidence interval (CI) for OSA risk per unit increase in anthropometric and body composition indicators (i.e., zBMI, FM%, FMI, FFMI, TMMI, CFMI, and FMR) were also examined.
Associations of OSA risk with metabolic abnormalities were explored using logistic regressions, and associations of OSA risk with metabolic indicators in children were further explored using generalized linear models. In the adjusted analyses, the same aforementioned covariates were adjusted in model 1, and the child BMI was further adjusted in model 2. In sensitivity analyses, child FMI was adjusted in model 2. Subgroup analyses were conducted to investigate the correlations by the child BMI (normal BMI, overweight/obesity) and sex (male, female). Missing values of a covariate were regarded as a category in adjusted analyses.
A 2-tailed p value was deemed statistically significant at <0.05. The statistical analyses were conducted using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).

3. Results

Among the 6013 children and adolescents who were investigated, 181 preschool children were excluded, and 832 were further excluded due to missing data regarding PSQ. Consequently, the final analysis included 5000 school-aged children and adolescents. Of these, 4428 (88.6%) were categorized as low-risk for OSA, whereas 572 (11.4%) were classified as high-risk. Table 1 presents the characteristics of the participants according to the risk of OSA. Compared to children with a low risk of OSA, those at high risk were more likely to be male (60.0% vs. 49.5%), have a family history of metabolic abnormalities (71.5% vs. 66.4%), experience passive smoking in the past week (37.1% vs. 26.6%), consume sugary beverages daily (7.3% vs. 6.8%), and have lower proportions of exclusive breastfeeding in the first six months (55.2% vs. 59.7%), normal weight (43.6% vs. 58.7%), and normal fat-normal muscle mass (69.7% vs. 78.4%).
As shown in Table 2, after covariate adjustments, the associations of overweight and obesity with high OSA risk were significant. The adjusted OR (aOR) for overweight was 1.53 (95% CI 1.22 to 1.92), and for obesity, it was 1.94 (95% CI 1.57 to 2.40). Abdominal obesity also significantly increased the odds of high OSA risk (aOR 1.59, 95% CI 1.31 to 1.93). Children and adolescents in the groups of high fat-normal muscle mass and high fat-high muscle mass were more likely to have high OSA risks compared to those in the normal fat-normal muscle mass group [aORs 1.39 (95% CI 1.03 to 1.88) and 2.05 (95% CI 1.56 to 2.69)], but not for those in the normal fat-high muscle mass group (aOR 1.21, 95% CI 0.84 to 1.73).
For anthropometric and body composition indicators, zBMI (aOR 1.19, 95% CI 1.12 to 1.27), FM% (aOR 1.03, 95% CI 1.02 to 1.03), FMI (aOR 1.08, 95% CI 1.04 to 1.11), CFMI (aOR 1.45, 95% CI 1.13 to 1.86), and FMR (aOR 3.03, 95% CI 2.04 to 4.50) were associated with increased odds of high OSA risk, while FFMI (aOR 1.01, 95% CI 0.95 to 1.07) and TMMI (aOR 1.01, 95% CI 0.95 to 1.08) were not associated with high OSA risk. Subgroup analyses showed that FM% (aOR 1.02, 95% CI 1.01 to 1.04), FMI (aOR 1.07, 95% CI 1.02 to 1.11), CFMI (aOR 1.88, 95% CI 1.26 to 2.80), and FMR (aOR 2.27, 95% CI 1.18 to 4.36) raised the risk of high OSA in overweight and obese children but not in normal-weight children. FFMI and TMMI, on the other hand, had no effect on OSA risk across BMI categories (p < 0.05, Figure 1).
In the adjusted model 1 for associations of OSA risk with metabolic abnormalities, children with high OSA risk had higher odds of low HDL-C levels (aOR 1.37, 95% CI 1.01 to 1.88) and high TG levels (aOR 1.34, 95% CI 1.06 to 1.71) compared to those with low OSA risk. In model 2, after adjusting the child BMI, the associations attenuated to non-significance (p > 0.05, Table 3). In sensitivity analyses, the associations remained similar after adjustment for child FMI. The associations were not significant in normal-BMI and overweight/obese children (Table S1) nor in boys or girls (Table S2). For continuous metabolic indices, after adjusting for covariates, including the child BMI, most associations were non-significant except for SBP, which was borderline statistically significant but not clinically meaningful (β −0.011, 95% CI −0.018 to −0.004, Table S3).

4. Discussion

This study comprehensively examines the associations between OSA risk, obesity, body composition, and metabolic abnormalities in school-aged children and adolescents. Our observations indicate that being overweight, obese, or having abdominal obesity significantly increases the likelihood of high OSA risk. Notably, children and adolescents with high fat mass, regardless of muscle mass, exhibited a significantly higher risk of OSA. Elevated body fat in those overweight and obese contributed to a higher risk of OSA, unlike those of normal weight. Furthermore, the relationships between OSA risk and metabolic abnormalities became non-significant after adjusting for the child BMI.
OSA is the prevailing kind of sleep-disordered breathing and signifies the severe manifestation of sleep-related issues [40]. The worldwide prevalence of childhood obesity, metabolic disorders, and OSA is rising [2,3,41]. For children and adolescents, studies have identified that overweight and obesity are the risk factors of sleep-disordered breathing [5]. Obesity is becoming a significant risk factor for pediatric OSA, particularly among school-aged children and adolescents, despite adenotonsillar hypertrophy being the most common risk factor [42,43]. In this population, our study found that anthropometric measurements can predict OSA, with significant associations between overweight, obesity, and OSA risk. Children who were obese had a higher risk of OSA than those who were overweight. Central adiposity is reported to be a significant risk factor for OSA in adults [44,45]. In children and adolescents, our study also found that abdominal obesity significantly increased the odds of high OSA risk. Our findings align with the prior study recruiting adolescents, showing a positive correlation between higher BMI and increased OSA risk [6].
The links between body composition measured by BIA and OSA have not been fully explored in children and adolescents. In adults, it is reported that OSA screens can use the muscle-to-fat ratio as an indicator in males [46]. Our study underscores the importance of considering comprehensive body composition rather than relying solely on BMI. High fat mass emerged as a crucial factor in elevating OSA risk, while muscle mass alone had no effect. Although muscle mass alone was not a critical factor for OSA risk, in children and adolescents with different body composition phenotypes, those with high fat-high muscle mass had the highest risk of OSA. This could be attributed to the combination of high fat mass and high muscle mass, indicating a generally higher overall body weight and volume, and to the likelihood of ectopic fat accumulation within muscle tissues in children with both high fat mass and high muscle mass [34,47]. Additionally, FMR, which comprehensively reflects body composition balance, markedly increased the OSA risk, indicating that the combined effects of high fat mass and inadequate muscle mass exacerbate the risk of OSA. Stratified analysis showed that higher body fat increased the OSA risk in overweight and obese children and adolescents but not in those who were normal-weight. This suggests that fat accumulation is a primary driver of OSA, emphasizing the need for body composition assessments and the importance of fat mass reduction, especially for obese children. This could be attributed to physiological differences between obese and nonobese airways, such as adipose tissue around the pharynx and neck and more crowding of the oropharynx in obese children [4,48], and accumulation of fat around the viscera and abdominal and thoracic walls, which leads to decreased lung volume and oxygen reserve [13].
Studies have linked OSA to a higher likelihood of negative metabolic conditions, with obesity serving as a common comorbidity in individuals with both OSA and metabolic syndrome [15]. Previous studies have tended to focus on one type of indicator, such as blood lipids, blood glucose, or blood pressure, with inconsistent results [10,15,49,50]. It was found that the links between OSA and some metabolic markers (high TG levels and low HDL-C levels) became statistically non-significant when the child BMI was taken into account. The associations were also non-significant after stratifying by the child BMI and sex. This suggests that obesity has a significant influence on the connection between OSA and metabolic problems. The findings align with previous research indicating that the association between OSA and metabolic dysfunction is predominantly determined by obesity rather than OSA [51]. Early or mild OSA may have a negligible effect on metabolic abnormalities; in long-term or severe cases, it may negatively impact the metabolic profile [6,10,52,53,54]. Prospective investigations are required to assess the enduring impact of OSA on metabolic health in children in the future.
Our study had strengths. We comprehensively investigated a wide variety of anthropometric and body composition measurements and metabolic biomarkers, targeting a general population rather than only obese children in many studies. We also used the validated sleep questionnaire to define the risk of OSA. The study also had limitations. The study’s cross-sectional design precluded the determination of causative relationships. Additionally, we did not use PSG to diagnose OSA; given the high demand for limited resources, our objective was to identify children with high OSA risk based on obesity and body composition and to understand negative changes in at-risk children to prioritize PSG testing. We did not exclude children with central sleep apnea (CSA), which may have caused bias in our findings. Future research warrants the use of PSG and the differentiation between OSA and CSA. Future research exploring the associations of segmental muscle mass with OSA risk would be beneficial.

5. Conclusions

Our study enhances comprehension of the intricate connections of obesity and body composition with OSA risk in children and adolescents. Elevated fat mass increases the risk of OSA, particularly in obese children. Regarding the associations between OSA risk and metabolic abnormalities, our analyses indicate that these relationships are largely mediated by obesity rather than the OSA risk itself. In the future, it is important to conduct longitudinal studies to examine the causative relationships and enduring effects of OSA on metabolic health in children, thereby guiding better screening and management practices.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/nu16152419/s1, Table S1: Associations of OSA risk with metabolic abnormalities, stratified by the child BMI; Table S2: Associations of OSA risk with metabolic abnormalities, stratified by child sex; Table S3: Associations of OSA risk with metabolic indices.

Author Contributions

Conceptualization of larger study, F.C., S.L., J.L. and X.Z.; conceptualization of present study, Z.L. and F.C.; investigation, Z.L., Y.C., F.C., S.L., J.L. and X.Z.; resources, F.C., S.L., X.Z. and J.L.; data curation, Z.L. and Y.C.; writing—original draft preparation, Z.L.; writing—review and editing, L.W., Y.C., Y.H., S.L., J.L., X.Z., J.T. and F.C.; supervision, F.C. and J.T.; funding acquisition, Z.L., S.L., F.C. and J.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by The National Key Research and Development Program of China (2022YFF0606202), National Natural Science Foundation of China (72104148), Public service development and reform pilot project of Beijing Medical Research Institute (BMR2021-3), Beijing Municipal Administration of Hospitals Incubating Program (Px2022052), Research Foundation of Capital Institute of Pediatrics (ERB-2023-02), Beijing Hospitals Authority Youth Programme (QML20211301), China Soong Ching Ling Foundation (2023-24).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Capital Institute of Pediatrics (SHERLL2022043; ethics approval date 19 August 2022).

Informed Consent Statement

We obtained written informed consent from all children or their guardians.

Data Availability Statement

The dataset is available upon reasonable request to the corresponding author. The data are not publicly available due to privacy.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Mokhlesi, B.; Temple, K.A.; Tjaden, A.H.; Edelstein, S.L.; Nadeau, K.J.; Hannon, T.S.; Manchanda, S.; Sam, S.; Barengolts, E.; Utzschneider, K.M.; et al. The association of sleep disturbances with glycemia and obesity in youth at risk for or with recently diagnosed type 2 diabetes. Pediatr. Diabetes 2019, 20, 1056–1063. [Google Scholar] [CrossRef] [PubMed]
  2. Magnusdottir, S.; Hill, E.A. Prevalence of obstructive sleep apnea (OSA) among preschool aged children in the general population: A systematic review. Sleep Med. Rev. 2024, 73, 101871. [Google Scholar] [CrossRef] [PubMed]
  3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 2024, 403, 1027–1050. [Google Scholar] [CrossRef] [PubMed]
  4. Kang, K.T.; Chou, C.H.; Weng, W.C.; Lee, P.L.; Hsu, W.C. Associations between adenotonsillar hypertrophy, age, and obesity in children with obstructive sleep apnea. PLoS ONE 2013, 8, e78666. [Google Scholar] [CrossRef] [PubMed]
  5. Kang, K.T.; Lee, P.L.; Weng, W.C.; Hsu, W.C. Body weight status and obstructive sleep apnea in children. Int. J. Obes. 2012, 36, 920–924. [Google Scholar] [CrossRef] [PubMed]
  6. Talib, A.; Roebroek, Y.G.M.; van Waardenburg, D.A.; van der Grinten, C.P.M.; Winkens, B.; Bouvy, N.D.; van Heurn, E. Obstructive sleep apnea in obese adolescents referred for bariatric surgery: Association with metabolic and cardiovascular variables. Sleep Med. 2020, 75, 246–250. [Google Scholar] [CrossRef]
  7. Bhattacharjee, R.; Kheirandish-Gozal, L.; Spruyt, K.; Mitchell, R.B.; Promchiarak, J.; Simakajornboon, N.; Kaditis, A.G.; Splaingard, D.; Splaingard, M.; Brooks, L.J.; et al. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: A multicenter retrospective study. Am. J. Respir. Crit. Care Med. 2010, 182, 676–683. [Google Scholar] [CrossRef]
  8. Piovezan, R.D.; Hirotsu, C.; Moizinho, R.; de Sá Souza, H.; D’Almeida, V.; Tufik, S.; Poyares, D. Associations between sleep conditions and body composition states: Results of the EPISONO study. J. Cachexia Sarcopenia Muscle 2019, 10, 962–973. [Google Scholar] [CrossRef]
  9. Glicksman, A.; Hadjiyannakis, S.; Barrowman, N.; Walker, S.; Hoey, L.; Katz, S.L. Body Fat Distribution Ratios and Obstructive Sleep Apnea Severity in Youth With Obesity. J. Clin. Sleep Med. 2017, 13, 545–550. [Google Scholar] [CrossRef]
  10. Lei, L.; Zhang, X.; Wang, B.; Lei, F.; Dai, L.; Sun, X.; Zhao, Y.; Zhu, P.; Zou, J. Effects of sleep-disordered breathing on serum lipid levels in children:a case control study. BMC Pediatr. 2024, 24, 220. [Google Scholar] [CrossRef]
  11. Brooks, D.M.; Kelly, A.; Sorkin, J.D.; Koren, D.; Chng, S.Y.; Gallagher, P.R.; Amin, R.; Dougherty, S.; Guo, R.; Marcus, C.L.; et al. The relationship between sleep-disordered breathing, blood pressure, and urinary cortisol and catecholamines in children. J. Clin. Sleep Med. 2020, 16, 907–916. [Google Scholar] [CrossRef]
  12. Lee, C.H.; Kang, K.T.; Chiu, S.N.; Chang, I.S.; Weng, W.C.; Lee, P.L.; Hsu, W.C. Association of Adenotonsillectomy with Blood Pressure among Hypertensive and Nonhypertensive Children with Obstructive Sleep Apnea. JAMA Otolaryngol. Head Neck Surg. 2018, 144, 300–307. [Google Scholar] [CrossRef]
  13. Blechner, M.; Williamson, A.A. Consequences of Obstructive Sleep Apnea in Children. Curr. Probl. Pediatr. Adolesc. Health Care 2016, 46, 19–26. [Google Scholar] [CrossRef] [PubMed]
  14. Sharma, S.K.; Kumpawat, S.; Goel, A.; Banga, A.; Ramakrishnan, L.; Chaturvedi, P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med. 2007, 8, 12–17. [Google Scholar] [CrossRef]
  15. Shamsuzzaman, A.; Szczesniak, R.D.; Fenchel, M.C.; Amin, R.S. Glucose, insulin, and insulin resistance in normal-weight, overweight and obese children with obstructive sleep apnea. Obes. Res. Clin. Pract. 2014, 8, e584–e591. [Google Scholar] [CrossRef] [PubMed]
  16. Beck, S.E.; Marcus, C.L. Pediatric polysomnography. Sleep Med. Clin. 2009, 4, 393–406. [Google Scholar] [CrossRef]
  17. Katz, S.L.; Witmans, M.; Barrowman, N.; Hoey, L.; Su, S.; Reddy, D.; Narang, I. Paediatric sleep resources in Canada: The scope of the problem. Paediatr. Child Health 2014, 19, 367–372. [Google Scholar] [CrossRef]
  18. von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P.; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007, 370, 1453–1457. [Google Scholar] [CrossRef] [PubMed]
  19. Chervin, R.D.; Hedger, K.; Dillon, J.E.; Pituch, K.J. Pediatric sleep questionnaire (PSQ): Validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000, 1, 21–32. [Google Scholar] [CrossRef]
  20. Li, X.D.; Tai, J.; Xu, Z.F.; Peng, X.X.; Feng, G.S.; Zhang, Y.M.; Zhang, J.; Guo, Y.L.; Wu, Y.X.; Shi, J.; et al. The validity and reliability of simplified Chinese version of the pediatric sleep questionnaire for screening children with obstructive sleep apnea syndrome in Beijing. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chin. J. Otorhinolaryngol. Head Neck Surg. 2016, 51, 812–818. (In Chinese) [Google Scholar] [CrossRef]
  21. Marcus, C.L.; Brooks, L.J.; Draper, K.A.; Gozal, D.; Halbower, A.C.; Jones, J.; Schechter, M.S.; Ward, S.D.; Sheldon, S.H.; Shiffman, R.N.; et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012, 130, e714–e755. [Google Scholar] [CrossRef]
  22. Liao, Z.; Wang, J.; Chen, F.; Chen, Y.; Zhang, T.; Liu, G.; Xie, X.; Tai, J. Association of Cesarean Delivery with Trajectories of Growth and Body Composition in Preschool Children. Nutrients 2022, 14, 1806. [Google Scholar] [CrossRef]
  23. Li, M.; Shu, W.; Zunong, J.; Amaerjiang, N.; Xiao, H.; Li, D.; Vermund, S.H.; Hu, Y. Predictors of non-alcoholic fatty liver disease in children. Pediatr. Res. 2022, 92, 322–330. [Google Scholar] [CrossRef]
  24. Wilke, M.S.; Maximova, K.; Henderson, M.; Levy, E.; Paradis, G.; O’Loughlin, J.; Tremblay, A.; Proctor, S.D. Adiposity in Children and CVD Risk: ApoB48 Has a Stronger Association With Central Fat Than Classic Lipid Markers. J. Clin. Endocrinol. Metab. 2016, 101, 2915–2922. [Google Scholar] [CrossRef]
  25. Huang, Y.; Gao, L.; Cheng, H.; Wang, X.; Dong, H.; Yan, Y.; Zhao, X.; Liu, J.; Shan, X.; Mi, J. Difference of glucose and lipid metabolism abnormalities and body fat between the Chinese and USA teenagers. J. Glob. Health 2023, 13, 04041. [Google Scholar] [CrossRef]
  26. World Health Organization. WHO Child Growth Standards SAS Igrowup Package; World Health Organization: Geneva, Switzerland, 2016. [Google Scholar]
  27. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr. Suppl. 2006, 450, 76–85. [Google Scholar]
  28. WHO Multicentre Growth Reference Study Group; World Health Organization. WHO Child Growth Standards: Length/Height-for-Age, Weightfor-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development; World Health Organization: Geneva, Switzerland, 2006. [Google Scholar]
  29. de Onis, M.; Onyango, A.W.; Borghi, E.; Siyam, A.; Nishida, C.; Siekmann, J. Development of a WHO growth reference for school-aged children and adolescents. Bull. World Health Organ. 2007, 85, 660–667. [Google Scholar] [CrossRef]
  30. de Onis, M.; Lobstein, T. Defining obesity risk status in the general childhood population: Which cut-offs should we use? Int. J. Pediatr. Obes. 2010, 5, 458–460. [Google Scholar] [CrossRef]
  31. McCarthy, H.D.; Ashwell, M. A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message--‘keep your waist circumference to less than half your height’. Int. J. Obes. 2006, 30, 988–992. [Google Scholar] [CrossRef]
  32. Sharma, A.K.; Metzger, D.L.; Daymont, C.; Hadjiyannakis, S.; Rodd, C.J. LMS tables for waist-circumference and waist-height ratio Z-scores in children aged 5-19 y in NHANES III: Association with cardio-metabolic risks. Pediatr. Res. 2015, 78, 723–729. [Google Scholar] [CrossRef]
  33. Wu, T.; Liao, Z.; Wang, J.; Liu, M. The Accumulative Effect of Multiple Postnatal Risk Factors with the Risk of Being Overweight/Obese in Late Childhood. Nutrients 2024, 16, 1536. [Google Scholar] [CrossRef]
  34. Gao, L.; Cheng, H.; Yan, Y.; Liu, J.; Shan, X.; Wang, X.; Mi, J. The associations of muscle mass with glucose and lipid metabolism are influenced by body fat accumulation in children and adolescents. Front. Endocrinol. 2022, 13, 976998. [Google Scholar] [CrossRef]
  35. WS/T 610-2018[S]; Reference of Screening for Elevated Blood Pressure among Children and Adolescents Aged 7~18 Years. National Health Commission of the People’s Republic of China: Beijing, China, 2018. (In Chinese)
  36. Fan, H.; Yan, Y.; Mi, J. Updating blood pressure references for Chinese children aged 3–17 years. Zhong hua Gao Xue Ya Za Zhi 2017, 25, 428–435. (In Chinese) [Google Scholar]
  37. Subspecialty Group of Rare Diseases; the Society of Pediatrics; Chinese Medical Association; Subspecialty Group of Cardiology; the Society of Pediatrics; Chinese Medical Association; Subspecialty Group of Child Health Care; the Society of Pediatrics; Chinese Medical Association; Subspecialty Group of Endocrinological; et al. Expert consensus on diagnosis and management of dyslipidemia in children. Zhonghua Er Ke Za Zhi 2022, 60, 633–639. (In Chinese) [Google Scholar]
  38. Chen, F.; Liu, J.; Yan, Y.; Mi, J.; China Child and Adolescent Cardiovascular Health (CCACH) Study Group. Abnormal Metabolic Phenotypes Among Urban Chinese Children: Epidemiology and the Impact of DXA-Measured Body Composition. Obesity 2019, 27, 837–844. [Google Scholar] [CrossRef]
  39. Rao, J.; Ye, P.; Lu, J.; Chen, B.; Li, N.; Zhang, H.; Bo, H.; Chen, X.; Liu, H.; Zhang, C.; et al. Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: A pooled analysis of 11 population-based studies. Ann. Med. 2022, 54, 1608–1615. [Google Scholar] [CrossRef]
  40. Tsampalieros, A.; Blinder, H.; Hoey, L.; Momoli, F.; Barrowman, N.; Feber, J.; Spitale, N.; Katz, S.L. Obstructive sleep apnea and hypertension in pediatric chronic kidney disease. Pediatr. Nephrol. 2019, 34, 2361–2370. [Google Scholar] [CrossRef]
  41. Reisinger, C.; Nkeh-Chungag, B.N.; Fredriksen, P.M.; Goswami, N. The prevalence of pediatric metabolic syndrome-a critical look on the discrepancies between definitions and its clinical importance. Int. J. Obes. 2021, 45, 12–24. [Google Scholar] [CrossRef] [PubMed]
  42. Lo Bue, A.; Salvaggio, A.; Insalaco, G. Obstructive sleep apnea in developmental age. A narrative review. Eur. J. Pediatr. 2020, 179, 357–365. [Google Scholar] [CrossRef]
  43. Katz, S.L.; Vaccani, J.P.; Barrowman, N.; Momoli, F.; Bradbury, C.L.; Murto, K. Does neck-to-waist ratio predict obstructive sleep apnea in children? J. Clin. Sleep Med. 2014, 10, 1303–1308. [Google Scholar] [CrossRef]
  44. Schwartz, A.R.; Patil, S.P.; Laffan, A.M.; Polotsky, V.; Schneider, H.; Smith, P.L. Obesity and obstructive sleep apnea: Pathogenic mechanisms and therapeutic approaches. Proc. Am. Thorac. Soc. 2008, 5, 185–192. [Google Scholar] [CrossRef] [PubMed]
  45. Simpson, L.; Mukherjee, S.; Cooper, M.N.; Ward, K.L.; Lee, J.D.; Fedson, A.C.; Potter, J.; Hillman, D.R.; Eastwood, P.; Palmer, L.J.; et al. Sex differences in the association of regional fat distribution with the severity of obstructive sleep apnea. Sleep 2010, 33, 467–474. [Google Scholar] [CrossRef] [PubMed]
  46. Kim, J.R.; Song, P.; Joo, E.Y. Sex Differences in Obstructive Sleep Apnea by Bioelectrical Impedance Analysis. J. Clin. Neurol. 2021, 17, 283–289. [Google Scholar] [CrossRef] [PubMed]
  47. Larson-Meyer, D.E.; Newcomer, B.R.; Ravussin, E.; Volaufova, J.; Bennett, B.; Chalew, S.; Cefalu, W.T.; Sothern, M. Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children. Diabetologia 2011, 54, 869–875. [Google Scholar] [CrossRef] [PubMed]
  48. Katz, E.S.; D’Ambrosio, C.M. Pediatric obstructive sleep apnea syndrome. Clin. Chest Med. 2010, 31, 221–234. [Google Scholar] [CrossRef] [PubMed]
  49. Kang, K.T.; Chiu, S.N.; Weng, W.C.; Lee, P.L.; Hsu, W.C. Comparisons of Office and 24-Hour Ambulatory Blood Pressure Monitoring in Children with Obstructive Sleep Apnea. J. Pediatr. 2017, 182, 177–183.e2. [Google Scholar] [CrossRef]
  50. Erdim, I.; Akcay, T.; Yilmazer, R.; Erdur, O.; Kayhan, F.T. Is Metabolic Syndrome Associated with Obstructive Sleep Apnea in Obese Adolescents? J. Clin. Sleep Med. 2015, 11, 1371–1376. [Google Scholar] [CrossRef]
  51. Koren, D.; Gozal, D.; Philby, M.F.; Bhattacharjee, R.; Kheirandish-Gozal, L. Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children. Eur. Respir. J. 2016, 47, 1152–1161. [Google Scholar] [CrossRef]
  52. Li, A.M.; Au, C.T.; Ng, C.; Lam, H.S.; Ho, C.K.W.; Wing, Y.K. A 4-year prospective follow-up study of childhood OSA and its association with BP. Chest 2014, 145, 1255–1263. [Google Scholar] [CrossRef]
  53. Fernandez-Mendoza, J.; He, F.; Calhoun, S.L.; Vgontzas, A.N.; Liao, D.; Bixler, E.O. Association of Pediatric Obstructive Sleep Apnea With Elevated Blood Pressure and Orthostatic Hypertension in Adolescence. JAMA Cardiol. 2021, 6, 1144–1151. [Google Scholar] [CrossRef]
  54. Kang, K.T.; Chiu, S.N.; Weng, W.C.; Lee, P.L.; Hsu, W.C. Analysis of 24H-our Ambulatory Blood Pressure Monitoring in Children with Obstructive Sleep Apnea: A Hospital-Based Study. Medicine 2015, 94, e1568. [Google Scholar] [CrossRef]
Nutrients 16 02419 g001
Figure 1. Associations of anthropometric and body composition indicators with OSA risk. Multivariate models were adjusted for maternal age at delivery, maternal history of gestational diabetes mellitus/hypertension, delivery mode, child sex, exclusive breastfeeding duration in the first six months, family history of metabolic abnormalities, annual family income, maternal education, paternal education, child age, sugary beverage consumption pattern, and passive smoking in the past week; a further adjusted for FFMI; b further adjusted for FMI; c further adjusted for TMMI. Abbreviations: OSA, obstructive sleep apnea; zBMI, BMI z score; FMI, fat mass index; FFMI, fat-free mass index; TMMI, total muscle mass index; CFMI, central fat mass index; FMR, fat-to-muscle mass ratio.
Figure 1. Associations of anthropometric and body composition indicators with OSA risk. Multivariate models were adjusted for maternal age at delivery, maternal history of gestational diabetes mellitus/hypertension, delivery mode, child sex, exclusive breastfeeding duration in the first six months, family history of metabolic abnormalities, annual family income, maternal education, paternal education, child age, sugary beverage consumption pattern, and passive smoking in the past week; a further adjusted for FFMI; b further adjusted for FMI; c further adjusted for TMMI. Abbreviations: OSA, obstructive sleep apnea; zBMI, BMI z score; FMI, fat mass index; FFMI, fat-free mass index; TMMI, total muscle mass index; CFMI, central fat mass index; FMR, fat-to-muscle mass ratio.
Nutrients 16 02419 g001
Table 1. Characteristics according to the risk of OSA.
Table 1. Characteristics according to the risk of OSA.
CharacteristicsLow-Risk for OSA (n = 4428)High-Risk for OSA
(n = 572)		p
Maternal age at delivery (year), Mean ± SD27.8 ± 4.327.6 ± 4.50.267
Maternal age at delivery (year), n (%)
<353917 (93.0)508 (94.1)0.368
≥35296 (7.0)32 (5.9)
Maternal history of gestational diabetes mellitus/hypertension, n (%)
Without4082 (92.2)525 (91.8)0.741
With346 (7.8)47 (8.2)
Delivery mode, n (%)
Vaginal delivery1985 (45.9)268 (48.3)0.298
Cesarean delivery2340 (54.1)287 (51.7)
Child sex, n (%)
Male2194 (49.5)343 (60.0)<0.001
Female2234 (50.5)229 (40.0)
Birthweight (g), Mean ± SD3393.7 ± 659.33369.1 ± 592.60.426
Birthweight (g), n (%)
<2500136 (3.9)16 (3.8)0.893
2500–39992927 (84.2)355 (83.5)
≥4000415 (11.9)54 (12.7)
Exclusive breastfeeding duration in the first six months, n (%)
yes2528 (59.7)302 (55.2)0.047
no1703 (40.3)245 (44.8)
Family history of metabolic abnormalities, n (%)
Without1490 (33.6)163 (28.5)0.014
With2938 (66.4)409 (71.5)
Annual family income (CNY), n (%)
<20,000760 (18.4)105 (19.7)0.708
20,000–120,0001403 (33.9)175 (32.9)
120,000–250,0001284 (31)171 (32.1)
≥250,000689 (16.7)81 (15.2)
Maternal education, n (%)
High School or less2371 (55.5)308 (55.8)0.749
College1838 (43)238 (43.1)
Above college64 (1.5)6 (1.1)
Paternal education, n (%)
High School or less2518 (59.2)335 (60.4)0.548
College1645 (38.7)205 (36.9)
Above college91 (2.1)15 (2.7)
Maternal current BMI (kg/m2), Mean ± SD24.1 (5.4)24.3 (5.5)0.376
Maternal current BMI (kg/m2), n (%)
<18.5206 (4.9)19 (3.5)0.443
18–231843 (44)231 (43)
23–27.51527 (36.5)208 (38.7)
≥27.5612 (14.6)79 (14.7)
Paternal current BMI (kg/m2), Mean ± SD26.3 (5.6)26.6 (5.2)0.298
Paternal current BMI (kg/m2), n (%)
<23916 (22.1)106 (19.8)0.006
23–27.52011 (48.4)235 (43.9)
≥27.51227 (29.5)194 (36.3)
Child age (year), Mean ± SD11.0 ± 3.011.1 ± 2.90.708
Sugary beverage consumption pattern, n (%)
≥1/day296 (6.8)41 (7.3)0.001
4–6/week372 (8.6)58 (10.3)
1–3/week1371 (31.7)217 (38.4)
<1/week2291 (52.9)249 (44.1)
Passive smoking in the past week, n (%)
no3141 (73.4)349 (62.9)<0.001
yes1137 (26.6)206 (37.1)
Child weight status, n (%)
Normal2592 (58.7)249 (43.6)<0.001
Overweight869 (19.7)131 (22.9)
Obesity952 (21.6)191 (33.5)
Child body composition phenotype, n (%)
Normal fat-normal muscle mass3459 (78.4)398 (69.7)<0.001
High fat-normal muscle mass351 (7.9)59 (10.3)
Normal fat-high muscle mass265 (6.0)37 (6.5)
High fat-high muscle mass338 (7.7)77 (13.5)
The percentages of participants with missing data on maternal age at delivery, delivery mode, birthweight, exclusive breastfeeding duration in the first six months, annual family income, maternal education, maternal current BMI, paternal education, paternal current BMI, sugary beverage consumption pattern, passive smoking in the past week, child weight status, and child body composition phenotype were 4.9%, 2.4%, 21.9%, 4.4%, 6.6%, 3.5%, 5.5%, 3.8%, 6.2%, 2.1%, 3.3%, 0.3%, and 0.3%, respectively. Abbreviation: OSA, obstructive sleep apnea; BMI, body mass index.
Table 2. Associations of obesity and body composition phenotype with OSA risk.
Table 2. Associations of obesity and body composition phenotype with OSA risk.
Crude OR (95% CI)pAdjusted OR (95% CI) *p
Child weight status
Normal1 1
Overweight1.57 (1.25, 1.97)<0.0011.53 (1.22, 1.92)<0.001
Obesity2.09 (1.71, 2.56)<0.0011.94 (1.57, 2.40)<0.001
Abdominal obesity
WHtR < 0.51 1
WHtR ≥ 0.51.74 (1.45, 2.09)<0.0011.59 (1.31, 1.93)<0.001
Body composition phenotype
Normal fat -normal muscle mass1 1
High fat-normal muscle mass1.46 (1.09, 1.96)0.0121.39 (1.03, 1.88)0.032
Normal fat-high muscle mass1.21 (0.85, 1.74)0.2911.21 (0.84, 1.73)0.314
High fat-high muscle mass1.98 (1.51, 2.59)<0.0012.05 (1.56, 2.69)<0.001
* Multivariate models were adjusted for maternal age at delivery, maternal history of gestational diabetes mellitus/hypertension, delivery mode, child sex, exclusive breastfeeding duration in the first six months, family history of metabolic abnormalities, annual family income, maternal education, paternal education, child age, sugary beverage consumption pattern, and passive smoking in the past week. Abbreviation: OSA, obstructive sleep apnea; WHtR, waist-to-height ratio.
Table 3. Associations of OSA risk with metabolic abnormalities.
Table 3. Associations of OSA risk with metabolic abnormalities.
Metabolic AbnormalitiesCrude OR (95% CI)pModel 1Model 2
Adjusted OR (95% CI)pAdjusted OR (95% CI)p
High TC levels1.22 (0.89, 1.67)0.2221.22 (0.88, 1.68)0.2281.17 (0.85, 1.61)0.339
High LDL-C levels1.31 (1.02, 1.68)0.0361.27 (0.99, 1.64)0.0631.11 (0.86, 1.44)0.425
Low HDL-C levels1.41 (1.04, 1.91)0.0281.37 (1.01, 1.88)0.0451.11 (0.80, 1.54)0.546
High TG levels1.38 (1.09, 1.75)0.0071.34 (1.06, 1.71)0.0151.08 (0.84, 1.40)0.531
IFG0.89 (0.56, 1.43)0.6420.81 (0.50, 1.31)0.3960.77 (0.48, 1.25)0.287
High UA levels1.13 (0.93, 1.36)0.2161.13 (0.92, 1.37)0.2450.88 (0.70, 1.09)0.240
Hypertension1.08 (0.84, 1.39)0.5681.05 (0.81, 1.36)0.7040.79 (0.59, 1.04)0.091
Model 1: adjusted for maternal age at delivery, maternal history of gestational diabetes mellitus/hypertension, delivery mode, child sex, exclusive breastfeeding duration in the first six months, family history of metabolic abnormalities, annual family income, maternal education, paternal education, child age, sugary beverage consumption pattern, and passive smoking in the past week; model 2: further adjusted for child BMI. Abbreviation: OSA, obstructive sleep apnea; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; IFG, impaired fasting glucose; UA, uric acid.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Liao, Z.; Chen, Y.; Wu, L.; Huang, Y.; Li, S.; Liu, J.; Zong, X.; Tai, J.; Chen, F. Associations of Obstructive Sleep Apnea Risk with Obesity, Body Composition and Metabolic Abnormalities in School-Aged Children and Adolescents. Nutrients 2024, 16, 2419. https://doi.org/10.3390/nu16152419

AMA Style

Liao Z, Chen Y, Wu L, Huang Y, Li S, Liu J, Zong X, Tai J, Chen F. Associations of Obstructive Sleep Apnea Risk with Obesity, Body Composition and Metabolic Abnormalities in School-Aged Children and Adolescents. Nutrients. 2024; 16(15):2419. https://doi.org/10.3390/nu16152419

Chicago/Turabian Style

Liao, Zijun, Yiren Chen, Lijun Wu, Yiying Huang, Shaoli Li, Junting Liu, Xinnan Zong, Jun Tai, and Fangfang Chen. 2024. "Associations of Obstructive Sleep Apnea Risk with Obesity, Body Composition and Metabolic Abnormalities in School-Aged Children and Adolescents" Nutrients 16, no. 15: 2419. https://doi.org/10.3390/nu16152419

APA Style

Liao, Z., Chen, Y., Wu, L., Huang, Y., Li, S., Liu, J., Zong, X., Tai, J., & Chen, F. (2024). Associations of Obstructive Sleep Apnea Risk with Obesity, Body Composition and Metabolic Abnormalities in School-Aged Children and Adolescents. Nutrients, 16(15), 2419. https://doi.org/10.3390/nu16152419

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop